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Dr Thoralf Sundt (Boston, Mass). Thanks, Paul, beautifully
presented, and I would like to say thanks for getting your slides
and your manuscript to me much earlier than I ever do for my
invited discussants.
It is an intriguing hypothesis and, I think, an important topic.
The volume/outcome issue seems to be a perennial topic, and it
was even raised yesterday here in this meeting. Strangely, multiple
studies have shown contradictory findings. It is much like the
on-pump coronary artery bypass report that we just finished
discussing, again a subject with many studies showing seemingly
exactly contrary results. The report yesterday regarding heart
transplantation suggested exactly the opposite of your work,
with higher volume associate with better outcomes.
I would have to say that my reading is that volume is not a good
surrogate for outcome. If we want to look at outcome, we ought to
look at outcome. I think we are all agreed that organizations such
as Leapfrog are looking under the wrong rock. If they want to look
at outcome, they ought to look at meaningful outcomes.
But I think you go beyond this point and address another issue
here—not just the question of whether or not volume is a good sur-
rogate, but a second question, which is implied in your hypothe-
sis—what does improve outcome, and, by inference, how can we
intervene to improve those outcomes beyond concentrating cases
in large-volume centers. It is a complex problem as it turns out.
This same debate is going on in the general surgical community
as they consider the introduction of the Surgical Care Improve-
ment Project (SCIP) measures and the correlation with surgical
site infections. The general surgeons are pulling their hair out, be-
cause they have seen a reduction in surgical site infections with the
introduction of the program, but when they now consider the effect
of each of the process variables one by one, they do not see good
correlation with the outcomes.
But I think that you have hit on the answer,which is simply that it
is the focus on process and the attention to outcome that is actually
important. I suspect that the participation in a process improvement
or quality-focused program amounts to ‘‘institutionalization’’ of
the ‘‘Hawthorn Effect’’—and, in fact, that might be a part of the ex-
planation for the volume effect—that high-volume centers have, of
necessity, improved process just by virtue of the actual quantity.
Although I agree with you up to this point, there are some issues
that I do not understand about your analysis. It is certainly possible
for an individual surgeon or system to focus on outcome, but not
actually hit the mark on all variables despite their best efforts.
What you have shown is that the patients in whom one meets the
process variables—process variables that have been shown to cor-
relate with good outcomes—have better outcomes. I could argue
that this is circular logic.ery c February 2012
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DInstead, can we consider the parameters that might be surro-
gates for a focus on quality measures? In other words, can we strat-
ify surgeons or institutions by their ‘‘batting average’’ in being
consistent with the quality outcomes? Presumably, those with
focus will hit the mark more often overall. Rather than looking
at high-volume surgeons and low-volume surgeons, can we look
at high-batting average surgeons and low-batting average surgeons
and then see how their patients do? You wound up tracking the in-
dividual patients to the adherence to the metrics. What about high-
compliance surgeons and low-compliance surgeons? So that is
question number one.
Number two, did you have any surgeons that operated in two
hospitals, two hospitals that might imply different systems factors
such as a different focus on quality? So, for example, a given sur-
geon in hospital A might have better or worse outcomes in hospital
B if the focus on quality at a systems level at that hospital is less.
Finally, what was the effect of the initiation of this program on
adherence to those quality measures? Did a given program demon-
strate better compliance with measures overall after joining the
program?
I would like to emphasize what might have gone past some of
the audience, because you went past it pretty quickly. This pro-
gram is not one that was developed to drive cases to Columbia
but one aimed at actually improving outcomes in the sites where
you have intervened. It is altruistic in that regard. Thus, I believe
that your work really answers the question that was posed during
the heart transplant presentation yesterday: how can we improve
quality in low-volume sites? Answer: Focus on quality.
Thanks. I really enjoyed your report very much.
Dr Kurlansky. Dr Sundt, thank you very much for your kind
comments. Unfortunately, the statistical necessity did not permit
us to effectively look at the hospital level or the surgeon level re-
garding their batting averages, because the models converge with
so few centers; only five centers and only 1 to 2 surgeons per cen-
ter. That is why we analyzed the data at the patient level. But it
would certainly be very instructive as time goes and we generate
more data to be able to track that.
We did not have any surgeons who operated at two hospitals in
this program. In fact, none of the surgeons in this program operated
at other hospitals. So we did not have access to try to assess that,
although there have been some interesting studies, reports in the
literature, regarding the effect of having, for example, a high-vol-
ume surgeon working in a low-volume program elsewhere and
whether their results correlated more with the low-volume centers
or the high-volume centers.
It is very difficult to be able to track exactly the effect of the pro-
gram, because at some of these centers we helped them start the
program. So there was not a program before. I can tell you this:The Journal of Thoracic and Cain those centers in which there was a program before, in every
case, we do know that the raw mortality declined. However, one
of the aspects of this program was the institution of an information
system that enabled us to track these sorts of results that did not
exist before. So I cannot even retrospectively go back and find
out what their performance measures were before we got there.
DrMarc Ruel (Ottawa, Ontario, Canada). Dear Paul, I greatly
enjoyed your presentation. I think, though, that there might be an
issue here in terms of the statistical power of the study. When you
are looking at dichotomous outcomes, power is not dependent on
the denominator but on the numerator (ie, the number of events).
For instance, with respect to mortality in your study, there were
roughly 20 events of the 2000 or so patients whom you studied.
So the power was fairly limited.
Therefore, I was wondering if you had the opportunity to calcu-
late what would be the power of your conclusions? For instance,
how certain are you and what power do you have to determine
that you would, for instance, have identified a 40% relative in-
crease in mortality in low-volume hospitals versus high-volume
hospitals? Were you able to get this information out of your data?
Thank you very much for a great talk.
Dr Kurlansky. You raise an incredibly important point as
pointed out yesterday so eloquently, that the absence of evidence
is not evidence of absence, the classic problem of type II errors.
And with only five centers, even with over 2000 patients, you
have to account for clustering within centers, and therefore the
power of this study to determine small differences or differences
in low event rates is very limited.
However, what I think is extremely important here is that in that
context where mortality and morbidity were not able to be distin-
guished, the power of compliance with National Quality Forum
measures was extremely well statistically correlated with the dif-
ference in outcome, which tells me that even if there was a differ-
ence that with larger numbers would be measurable between the
low-volume and the high-volume programs, that is not nearly as
powerful a predictor as the National Quality Forum focus on qual-
ity compliance. Also, I think that is probably consistent with what
was found with the review of the STS database that I alluded to
where there are over a million patients, and there was a statistical
correlation between outcome and volume, the degree to which
volume contributed to the variance in the overall quality score
was only 1%. So, although it might be a predictor or it might ac-
tually be involved and we were not able to see it with the limited
power of this study, I think that perhaps that limitation in power is
a benefit to this study, because the fact that we were able to see
some other parameter very powerfully highlights the point that
process is much more important than volume in determining
outcome.rdiovascular Surgery c Volume 143, Number 2 293
